Table 2.
Items |
All
(n = 229) |
Low serum albumin
(n = 150) |
Normal serum albumin
(n = 79) |
Test method | Test statistic | p-Values |
---|---|---|---|---|---|---|
Intubation | 72 (31.6%) | 65 (43.6%) | 7 (8.9%) | Chi square | 28.88 | <0.001* |
Pneumonia | 80 (35.1%) | 69 (46.3%) | 11 (13.9%) | Chi square | 23.77 | <0.001* |
Cerebral vasospasm | 102 (44.5%) | 76 (50.7%) | 26 (32.9%) | Chi square | 6.60 | 0.010* |
Delayed cerebra infarction | 40 (17.5%) | 27 (18.0%) | 13 (16.5%) | Chi square | 0.09 | 0.770 |
Rebleeding | 18 (7.9%) | 15 (10.1%) | 3 (3.8%) | Chi square | 2.79 | 0.095 |
Length of hospital stay (days, median) | 10.19 ± 10.42 | 13.05 ± 11.34 | 4.76 ± 5.07 | Kruskal | 53.54 | 0.001* |
Length of ICU stay (days) | 9.54 ± 10.36 | 12.15 ± 11.44 | 4.60 ± 5.11 | Kruskal | 42.77 | 0.001* |
Poor outcome | 46 (20.1%) | 45 (30.0%) | 2 (2.5%) | Chi square | 23.94 | 0.001* |
Discharge outcome | Chi square | 32.26 | 0.001* | |||
Death | 4 (1.7%) | 4 (2.7%) | 0 (0%) | Chi square | 2.14 | 0.350 |
Vegetative stage | 10 (4.4%) | 9 (6.0%) | 1 (1.3%) | Chi square | 2.78 | 0.185 |
Severe disability | 32 (14.0%) | 32 (21.3%) | 1 (1.3%) | Chi square | 16.90 | 0.001* |
Mild disability | 39 (17.0%) | 30 (20.0%) | 9 (11.4%) | Chi square | 2.71 | 0.100 |
Recovery | 144 (62.9%) | 75 (50.0%) | 68 (86.1%) | Chi square | 28.72 | 0.001* |
6-month follow-up outcome | Chi square | 10.38 | 0.040* | |||
Death | 25 (10.9%) | 15 (10.0%) | 5 (6.3%) | Chi square | 1.17 | 0.280 |
Vegetative stage | 2 (0.9%) | 2 (1.3%) | 0 (0%) | Fisher | - | 0.546 |
Severe disability | 10 (4.4%) | 10 (6.7%) | 0 (0%) | Chi square | 5.51 | 0.045* |
Mild disability | 22 (9.6%) | 14 (9.3%) | 13 (16.5%) | Chi square | 2.52 | 0.112 |
Recovery | 156 (68.1%) | 95 (63.3%) | 61 (77.2%) | Chi square | 4.59 | 0.032* |
Measurement data are expressed as means ± standard deviation (SD) and counting data are expressed as a percentage.
p ≤ 0.05: low serum albumin group vs. normal serum albumin group. ICU, intensive care unit.